Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for amnesia due to electroconvulsive therapy
IRCT20191218045795N4Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thiamine in schizophrenia, schizoaffective disorder, affective disorder and 2 more, sponsored by Kurdistan University of Medical Sciences. Started Feb 2020; status: completed.
02
Drugs
thiamine
03
Conditions
schizophreniaschizoaffective disorderaffective disorderobsessive compulsive disorder (OCD)amnesia
Beyond the preview
Go deeper on IRCT20191218045795N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191218045795N4.